Hikma Pharmaceutical | HIK - Equity Capital And Reserves

Stock Price
1,445.00
Daily Change
5.00 0.35%
Monthly
4.90%
Yearly
-30.13%
Q2 Forecast
1,414.37

Hikma Pharmaceutical reported $2.59B in Equity Capital and Reserves for its fiscal semester ending in December of 2025.





Equity Capital And Reserves Change Date
Almirall EUR 1.49B 24.03M Dec/2025
argenx SE USD 7.32B 1.23B Dec/2025
AstraZeneca USD 47.33B 1.33B Mar/2026
Autolus Therapeutics Ltd USD 108.83M 69.3M Mar/2026
Bayer EUR 28.85B 2.9B Mar/2026
Fresenius EUR 19.77B 1.14B Dec/2025
Genmab DKK 5.85B 96M Dec/2025
GlaxoSmithKline GBP 17.42B 1.05B Mar/2026
GRIFOLS EUR 5.46B 171M Mar/2026
Hikma Pharmaceutical USD 2.59B 42M Dec/2025
Lakefront Biotherapeutics EUR 3.25B 17.5M Mar/2026
Lonza CHF 9.13B 513M Dec/2025
Merck EUR 29.74B 1.15B Mar/2026
Orion EUR 1.12B 162.1M Mar/2026
Recordati EUR 2.06B 140.52M Mar/2026
Roche Holding CHF 33.8B 758M Dec/2025
Sanofi EUR 72.81B 1.1B Mar/2026
UCB EUR 10.87B 1.18B Dec/2025